EIS and VCT Limits Doubled: A Game Changer for UK Startups

In a significant boost for early-stage innovators, the UK Treasury has announced a doubling of investment limits under the Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) programmes. Effective from April 2026, founders can now raise up to £24 million lifetime (up from £12 million) and £10 million annually (up from £5 million), with particular benefits for knowledge-intensive businesses in high-growth sectors like artificial intelligence, biotechnology, and advanced manufacturing.

This move addresses a long-standing friction point: UK founders frequently outgrew early-stage tax relief schemes, forcing them into less favourable commercial fundraising paths or relocation. The expanded limits signal Treasury intent to keep growth-stage companies anchored in the UK ecosystem and unlock patient capital for the founders tackling genuinely hard problems.

For startup operators, this is not headline noise—it's a structural change in how you can finance the next phase of growth without diluting founders or ceding control to traditional venture firms. But the rules come with conditions, and understanding them is critical before you approach investors or set your fundraising strategy.

What Changed: The New Numbers and Gross Assets Test

The Treasury announcement, detailed in April 2026 guidance, reflects two core changes:

• Lifetime investment limit: Doubled from £12 million to £24 million per company under both EIS and VCT.
• Annual investment limit: Doubled from £5 million to £10 million per tax year per company.
• Gross assets test: For knowledge-intensive companies, the gross assets threshold has been raised significantly—now permitting companies with up to £15 million in gross assets (previously £10 million) to remain eligible for EIS relief.

The emphasis on "knowledge-intensive" is deliberate. The Treasury defines these as companies whose workforce comprises a substantial proportion of highly educated professionals (typically with degrees in STEM or equivalent) and which derive significant income from intellectual property, proprietary processes, or advanced technical services. This includes AI, biotech, software, advanced materials, and cleantech—precisely the sectors UK policy wants to nurture.

For VCTs specifically, the increased limits mean larger fund commitments to individual portfolio companies without breaching concentration rules, making it easier for smaller VCTs to back meaningful growth rounds in their best performers.

According to HM Treasury's Spring 2026 Budget documents, the changes are intended to "unlock an additional £2–3 billion in patient capital for knowledge-intensive startups over the next three years." That's real money flowing into the ecosystem.

Why This Matters for Your Fundraising Strategy

If you're a founder of a knowledge-intensive business at the £2–5 million raised stage, this change is immediate and material to how you structure your next round.

Before April 2026 (the old regime)

You likely faced this scenario: You'd raised £4–5 million via EIS and early VCT investors. Your next £3–4 million round would breach the £5 million annual limit or push you toward the £12 million lifetime cap. You'd either:

• Wait and raise in two tranches across two tax years (slowing momentum).
• Shift to conventional VC with higher dilution and founder drag.
• Seek growth equity at a higher valuation (less patient, more governance burden).

After April 2026 (the new regime)

You can now raise £10 million in a single tax year, and up to £24 million lifetime. This means:

• Faster capital deployment: Close a larger round in a single funding event without artificial delays.
• Investor diversity: More EIS/VCT investors compete for your deal, which means better terms and less founder pressure.
• Tax relief retention: Your shareholders—especially angels and early employees via EIS and SEIS schemes—keep their tax upside for longer into your growth phase.
• Runway extension: You can fund 18–24 months of growth without returning to market again, reducing fundraising fatigue.

The practical impact: A Series A or early Series B in a knowledge-intensive startup can now be substantially or entirely structured through EIS/VCT, reducing the need to bring in institutional VC with its governance, board seats, and preference structures.

Qualifying as Knowledge-Intensive: The Criteria You Must Meet

The doubling is conditional. Not every startup qualifies. HMRC has published strict criteria for what counts as "knowledge-intensive," and you need to ensure your company ticks the boxes before you pitch to EIS/VCT investors or claim relief.

Core requirements for knowledge-intensive status

Staff composition: At least 20% of your workforce must hold a degree in a relevant discipline (STEM, medicine, law, economics, design) or have equivalent professional qualification. If you're a 10-person team, two people must meet this threshold.

Revenue from qualifying IP: At least 50% of your revenue must come from:

• Intellectual property you own or develop (patents, proprietary software, licensed algorithms).
• Services reliant on proprietary processes or specialist expertise.
• Products incorporating significant original research or development.

This is where many founders stumble. If you're a SaaS company selling a standard integration platform built on open-source libraries with a sales team larger than your engineering team, you may not qualify. If you're selling a proprietary ML model, advanced diagnostic tool, or specialised industrial software, you likely do.

Independent review: For EIS claims above £1 million in any three-year period, you'll need an independent HMRC-approved advisor to confirm knowledge-intensive status. HMRC's guidance on advance assurance sets out the process. This costs £2,000–£5,000 but is non-negotiable and worth doing early.

Companies House and regulatory alignment

You'll need to file the required paperwork at Companies House confirming knowledge-intensive status. This is now a standard filing requirement and is checked by both HMRC and VCT/EIS fund managers before capital is drawn.

If your company fails the test after receiving capital, investors lose relief retroactively, and you face a clawback liability. It's not theoretical—HMRC has been increasingly active in enforcement, particularly post-2023.

The Gross Assets Test: What It Means for Scaling

One of the biggest practical constraints under the old EIS rules was the gross assets threshold. Companies approaching £10 million in gross assets became ineligible, forcing founders to restructure or split entities—a messy workaround.

The new £15 million threshold for knowledge-intensive companies removes this cliff edge. You can now raise and deploy capital to scale operations, build inventory, acquire equipment, or make strategic hires without hitting a regulatory wall at exactly the moment you need growth investment most.

Gross assets definition: This is total assets (cash, equipment, IP, receivables, inventory) minus liabilities, calculated at the time of investment. It's not revenue; it's your balance sheet size.

For example:

• A biotech startup with £8 million in cash, £4 million in lab equipment, and £1 million in liabilities = £13 million gross assets. Previously ineligible. Now eligible under the £15 million threshold.
• A SaaS company valued at £50 million by private investors may still have only £6 million in gross assets (mostly intangibles and cash). Still eligible.

This distinction matters because it means growth-stage companies with strong asset bases—manufacturing, biotech, cleantech—are newly eligible for EIS/VCT, not just asset-light SaaS firms.

How to Access This Capital: A Founder's Roadmap

Step 1: Confirm your eligibility (Month 1)

Don't assume you're knowledge-intensive. Run a forensic check:

• Pull your payroll and degree/qualification records. Calculate the percentage of staff meeting the education threshold.
• Analyse your P&L: What percentage of revenue comes from proprietary IP or specialist services?
• Pull your latest accounts from Companies House. Calculate gross assets.
• Consider engaging an HMRC-approved EIS adviser (typically chartered accountants or tax specialists). They'll cost £1,500–£3,000 for initial assessment but will save you months of friction with investors.

Step 2: Secure advance assurance (Months 1–3)

If you're raising above £1 million, file for advance assurance with HMRC. The process is documented on gov.uk. It typically takes 4–8 weeks and gives you a certificate that removes investor risk—critical for attracting EIS/VCT capital.

The application includes:

• Business plan and financial projections (18–24 months forward).
• Evidence of knowledge-intensive status (staffing data, IP register, revenue breakdown).
• Gross assets calculation and supporting accounts.
• An adviser's opinion letter.

Step 3: Identify and pitch to EIS/VCT investors (Months 2–5)

The EIS/VCT ecosystem is fragmented but well-developed in the UK. Key player categories:

Dedicated EIS/VCT platforms: Crowdcube, SeedRS, and Seedlegals connect founders with EIS-eligible investors. Crowdcube has facilitated over £500 million in EIS-backed raises.

Specialist VCTs: Octopus Ventures, BGF (Business Growth Fund), and regional development funds (e.g., Midlands Engine Investment Fund) all offer EIS and VCT-structured capital. With the new £24 million limits, they're actively expanding portfolio company follow-on sizes.

Angels and syndicates: AngelList UK, Dynamo, and local angel networks are increasingly structured to offer EIS relief. The doubled limits make it easier to consolidate multiple small EIS cheques into cohesive larger rounds.

Corporate venture arms: Many large corporates (tech, pharma, industrials) now use VCT structures to back strategic startups while offering tax relief to their own investors—a win-win for younger firms needing both capital and corporate partnership.

Step 4: Structure your terms (Months 3–6)

EIS and VCT capital comes with regulatory strings, but they're generally founder-friendly compared to institutional VC:

• Qualifying investor restrictions: EIS allows connected investors (founders, employees) to invest with relief—unusual in VC. This is excellent for founder top-ups and employee option pool equity.
• Equity vs. debt: EIS is equity-only; VCTs can hold both. Both allow convertible notes if structured correctly, but straight equity is simpler.
• No exit timeline: EIS and VCT relief is tax-based, not fund-based. Investors don't have a defined exit window like VC funds do. This means longer-term, more patient capital.
• Reinvestment relief: If your investors' earlier EIS gains are reinvested, they can avoid capital gains tax entirely—a powerful incentive for follow-on rounds.

Work with a tax-aware corporate counsel (expected cost: £5,000–£15,000) to ensure your articles, share class structure, and terms are EIS/VCT-compliant. Missteps here can disqualify investors retroactively.

Sector Spotlight: Who Benefits Most?

The Treasury's emphasis on knowledge-intensive business is deliberate. Certain sectors are now particularly attractive to EIS/VCT investors under the new rules:

AI and machine learning

If your team comprises ML engineers and data scientists, you're knowledge-intensive by definition. If your revenue comes from proprietary models or licensed algorithms, you meet the IP test. AI startups have historically had to choose between UK EIS (capped size) and US VC (less control). The doubled limits now allow UK AI founders to raise £24 million without compromise.

Biotech and life sciences

Biotech historically struggled with EIS gross assets caps because R&D equipment and inventory inflate balance sheets. The raised £15 million threshold opens the door for biotech Series A and B rounds. Expect significant VCT capital flowing into this space in 2026–2027.

Cleantech and advanced materials

Similar to biotech: capital-intensive, IP-rich, knowledge-intensive. Companies like Notpla (compostable packaging), Pangolin Sea (ocean robotics), and similar deep-tech startups now have a viable domestic funding path beyond US venture.

Software and SaaS (with caveats)

Not all SaaS qualifies. Generic B2B software with standard architecture and a large sales team may not meet the "50% from IP" test. But founders building proprietary algorithms (pricing intelligence, ML-driven insights, security tech) are eligible. The doubled limits particularly help prosaic SaaS founders avoid US VC by raising modestly larger UK rounds instead.

Risks and Gotchas to Navigate

The expanded scheme is attractive, but there are genuine landmines:

HMRC enforcement

The tax authority has increased EIS/VCT audits post-2023. If HMRC later determines your company doesn't meet knowledge-intensive criteria, investors lose relief retroactively. The company and shareholders face clawback liability and back-tax bills. This is not rare—affected companies have faced six-figure disputes.

Mitigation: Get advance assurance in writing. Keep detailed records of staff qualifications and revenue sources. Retest annually, especially if you're hiring sales staff or shifting product mix.

Valuation pressure

EIS investors are tax-motivated. Some will anchor valuations to the EIS-eligible discount (typically 30–50% discount to commercial VC valuation) on the logic that relief is a subsidy. Negotiate valuations based on fundamentals, not tax relief. Your growth metrics and market opportunity should drive price, not the investor's tax appetite.

Investor quality

The EIS/VCT ecosystem includes excellent operators and tax-driven tourists. Crowdfunding platforms and certain syndicates attract passive investors interested only in relief. Vet your lead investors: Do they add value? Will they back you in a crisis? Can they help with future fundraising?

Redemption and secondary sales

VCT investors can redeem shares after five years with tax relief intact. This creates exit pressure even if your business hasn't exited. Structure redemption terms carefully, and build coalitions with long-term investors (angels, employees) who aren't subject to redemption pressure.

Forward Look: What's Next for EIS/VCT in 2026–2027

The April 2026 changes are part of a broader UK industrial strategy pivot: shift capital from short-term trading and financial engineering toward long-term growth investment in deep tech and knowledge-intensive sectors.

Expected trends:

• Regional growth: Innovate UK and regional development funds are aligning with EIS/VCT to deploy capital outside London. If you're building in Manchester, Edinburgh, or Bristol, expect improved investor interest.
• Longer hold periods: With the expanded limits, founders and investors can now build mid-scale businesses (£20–100 million revenue) without pressure for venture-scale exits. Expect more founder-friendly exit timelines.
• Crossover funding: US VCs are increasingly comfortable with EIS/VCT-structured co-investment rounds. This allows you to mix UK tax-advantaged capital with US operators' networks and experience.
• Corporate buyer interest: Large industrials and tech companies are using VCT to back potential acquirees. Expect more strategic investment activity, especially in AI, biotech, and cleantech.

The policy intent is clear: keep UK founders building in the UK rather than chasing Silicon Valley capital. The doubled limits are the Treasury's bet that founders will choose £24 million of patient, UK-domiciled capital over the uncertainty of US VC if given the option.

Conclusion: Act Now on Your Eligibility

The EIS/VCT limit increase from £12 million to £24 million is a genuine structural shift in UK startup financing. If you're a founder of a knowledge-intensive business at the £2–8 million raised stage, this change likely applies to you—and you should act now to confirm eligibility and build it into your fundraising strategy.

The steps are clear: confirm knowledge-intensive status, secure advance assurance from HMRC, identify aligned investors, and structure terms with tax expertise. The payoff is meaningful—access to patient, founder-friendly capital with minimal dilution and no venture governance drag.

The window is now. VCTs and EIS investors are actively recalibrating their deployment strategies around the new limits. First-mover advantage goes to founders with advance assurance in hand and a clear capital strategy aligned to the regime.

Don't leave UK patient capital on the table. Your growth phase may depend on it.